US Broker Ratings

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 58.3% Upside Potential in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector focusing on over-the-counter solutions, is capturing the attention of investors with a notable potential..

Privia Health Group, Inc. (PRVA) Stock Analysis: Unveiling a 22.51% Potential Upside in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA) is capturing investors’ attention with its robust growth trajectory, particularly highlighted by a potential upside of 22.51% based on the..

DENTSPLY SIRONA Inc. (XRAY): Investor Outlook with a Promising 27.49% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 33.86% Potential Upside in Gene Editing Innovation

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology sector with its groundbreaking CRISPR/Cas9 gene-editing platform, poised to transform the treatment landscape for..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a Potential 156.50% Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a notable player in the biotechnology sector, has captured investor attention with its focus on developing innovative therapies for rare and..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 76% Potential Upside Awaits Investors

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving out a niche in the medical devices sector, specifically within the transformative space of surgical robotics for urology. Headquartered..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 42.3% Potential Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers a fascinating investment opportunity characterized..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Strong Revenue Growth Amidst Clinical Trial Progress

Investors eyeing the biotechnology sector should consider Avidity Biosciences, Inc. (NASDAQ: RNA), a trailblazer in RNA therapeutics with a market capitalization of $10.26 billion. This San..

Glaukos Corporation (GKOS) Stock Analysis: Uncovering a 35.69% Potential Upside in the Medical Device Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, is capturing investor attention with a significant potential upside of 35.69% based on its average..

Option Care Health, Inc. (OPCH) Stock Analysis: Unlocking a 36% Upside Potential for Investors

Option Care Health, Inc. (NASDAQ: OPCH), a key player in the healthcare sector, specifically within the medical care facilities industry, is currently capturing the attention of..

Telix Pharmaceuticals (TLX) Stock Analysis: An Australian Biotech with Nearly 100% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX) is garnering significant attention from investors due to its robust growth prospects and a near-doubling potential upside, as indicated by recent..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 32% Potential Upside

As the healthcare sector continues to draw investor attention, Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out with its promising potential upside of 32.29%. With a..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings Signal Growth Potential in Biotech Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS), a rapidly expanding player in the biotechnology sector, is capturing investor attention with its innovative genetic medicine solutions. Headquartered in Pittsburgh,..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Giant with 18.5% Revenue Growth and a Promising Investor Outlook

The Ensign Group, Inc. (NASDAQ: ENSG), a key player in the healthcare sector, stands out in the medical care facilities industry with a robust market capitalization..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Potential 31% Upside in the Precision Oncology Market

Revolution Medicines, Inc. (NASDAQ: RVMD) stands at the forefront of the biotechnology industry, focusing on the development of targeted therapies for RAS-addicted cancers. With a market..

Repligen Corporation (RGEN) Stock Analysis: A 25% Upside Potential in the Healthcare Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the life sciences sector, offers a compelling investment narrative with a projected upside of 25.45%. As a leader..

ADMA Biologics Inc (ADMA) Stock Analysis: A Robust 76% Upside Potential Beckons Investors

ADMA Biologics Inc (NASDAQ: ADMA), a pioneering entity in the biotechnology sector, is gaining traction among investors with its promising market stance and significant upside potential...

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Promising 77% Upside in the Biotech Sector

Soleno Therapeutics, Inc. (SLNO), a prominent player in the healthcare sector, specifically within the biotechnology industry, has captured the attention of investors with its promising financial..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Pioneer with a 44% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of..

Masimo Corporation (MASI) Stock Analysis: A Look at a 33% Potential Upside Amidst Strong Buy Ratings

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, specifically within the medical devices industry, offers investors a compelling opportunity with a potential upside..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds